Covexin 10 (fridge) POM-VPS suspension for injection for sheep and cattle

Product Description

Covexin 10 suspension for injection for sheep and cattle

Each 1 ml of vaccine contains: Active substances: C. perfringens type A toxoid ≥ 0.9 U3 C. perfringens type B & C (β) toxoid ≥ 12.4 U1 C. perfringens type D (ε) toxoid ≥ 5.1 U1 C. chauvoei whole culture, inactivated meets Ph. Eur.2 C. novyi toxoid ≥ 1.2 U1 C. septicum toxoid ≥ 3.6 U1 C. tetani toxoid ≥ 2.5 U1 C. sordellii toxoid ≥ 0.8 U1 C. haemolyticum toxoid ≥ 16.5 U3 1 In-house ELISA 2 Challenge test according to Ph. Eur. 3 In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes.

Amount(s) to be administered and administration route

Sheep – from 2 weeks of age: Dose – 1 ml. Cattle – from 2 weeks of age: Dose – 2 ml. Administration: By subcutaneous injection at a suitable site.

The recommended site is the loose skin on the side of the neck. The bottle should be well shaken before any vaccine is withdrawn. Syringes and needles should be sterile before use and the injection should be made through an area of clean, dry skin taking precautions against contamination. Basic vaccination scheme: Two doses should be administered, 4-6 weeks apart (see section 4.2 and 4.4).

Re-vaccination scheme: A single dose should be administered every 6 to 12 months after the basic vaccination scheme (see also point 4.2). Use in pregnancy: To provide passive protection of the offspring, via the colostrum, a single booster dose should be administered between 8 and 2 weeks before parturition, provided that animals have received a full basic vaccination course before pregnancy.

View other products in Products »